Stomach Diseases  >>  naproxen/esomeprazole  >>  Phase 3
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
naproxen/esomeprazole / Generic mfg.
NCT01129011: Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers Compared to Non-steroidal Antiinflammatory Drug (NSAID) Naproxen

Completed
3
420
US
PN400 (VIMOVO), Vimovo, Naproxen, Naprosyn
POZEN
Gastric Ulcer
09/08
10/08
NCT00594854: Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers in High Risk Subjects Compared to Arthrotec

Terminated
3
20
US
PN400 (VIMOVO), Vimovo, Diclofenac/Misoprostol, Arthrotec
POZEN
Gastric Ulcer
09/08
09/08
NCT00527787: Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers Compared to Non-steroidal Antiinflammatory Drug (NSAID) Naproxen

Completed
3
434
US
PN400 (VIMOVO), Vimovo, Naproxen, Naprosyn
POZEN
Gastric Ulcer
10/08
10/08
NCT00527904: A 12-month, Phase 3, Open-label, Multi-center Study to Evaluate the Long-term Safety of PN400 (VIMOVO)

Completed
3
239
US
PN400 (VIMOVO), Naprosyn, Nexium, PN 400 (VIMOVO)
POZEN
Gastric Ulcer
03/09
03/09

Download Options